Referencia

Cancer Cell. 2010 Dec 14;18(6):641-54

Autores

Manchado E, Guillamot M, de Cárcer G, Eguren M, Trickey M, García-Higuera I, Moreno S, Yamano H, Cañamero M, Malumbres M.

Resumen

La salida de mitosis ha sido recientemente propuesta como diana en la terapia contra el cáncer. En este estudio, mediante el uso de ratones modificados genéticamente, hemos demostrado como la eliminación condicional del cofactor Cdc20 tanto en células primarias como en fibroblastos transformados resulta en una parada permanente en mitosis que en todos los casos conduce a la muerte de la célula por apoptosis. Así, mientras el tratamiento de fibrosarcomas agresivos con las actuales drogas antimitóticas resulta en un efecto limitado, la ablación de Cdc20 favorece la completa regresión del tumor. Además, la parada permanente en mitosis provocada por la ausencia de Cdc20 nos ha permitido delinear los requerimientos esenciales de la salida de mitosis en células de mamíferos. Este análisis ha puesto de manifiesto la importancia de la de la quinasa Mastl en el mantenimiento del estado mitótico mediante la inhibición de la fosfatasa PP2A-B55α,δ.

Descripción

Targeting mitotic exit has been recently proposed as a relevant therapeutic approach against cancer. By using genetically engineered mice we show that the APC/C cofactor Cdc20 is essential for anaphase onset in vivo in embryonic or adult cells, including progenitors/stem cells. Ablation of Cdc20 results in efficient regression of aggressive tumors whereas current mitotic drugs display limited effects. Yet, Cdc20-null cells can exit upon concomitant inactivation of Cdk1 and the kinase Mastl (Greatwall). This mitotic exit depends on the activity of PP2A phosphatase complexes containing B55α or B55δ regulatory subunits. These data reveal critical players of mitotic exit in mammals and provide new avenues for manipulating the balance between apoptotic cell death and mitotic exit in tumor cells.

Imágen artículo Febrero

REFERENCIA DEL GRUPO E INVESTIGADOR
Eusebio Manchado está realizando la Tesis Doctoral en el grupo de División Celular y Cáncer dirigido por el Dr. Marcos Malumbres en el Centro Nacional de Investigaciones Oncológicas (CNIO). En la actualidad el trabajo del grupo se centra fundamentalmente en el estudio de los principales reguladores mitóticos y su posible implicación en cáncer mediante el desarrollo de modelos de ratón modificados genéticamente.

Descárgate este artículo aquí.
Más artículos en la revista SEBBM.

Did you publish an interesting article recently?

Send it through our application form and we will contact you. Age limit: 32.

The selected articles will participate at the Award to the best article of young people of the SEBBM which will be given during SEBBM conference, that will take place at Spain (free registration, travel and accommodation).

More articles of the month

The structure of a polygamous repressor reveals how phage-inducible chromosomal islands spread in nature

01-11-2019

Stl is a master repressor encoded by Staphylococcus aureus pathogenicity islands (SaPIs) that maintains integration of these elements in the bacterial chromosome. After infection or induction of a resident helper...

Read more

Self-Assembling ELR-Based Nanoparticles as Smart Drug-Delivery Systems Modulating Cellular Growth via Akt

01-10-2019

This work investigates the physicochemical properties and in vitro accuracy of a genetically engineered drug delivery system based on elastin-like block recombinamers. The DNA recombinant technics allowed us to create...

Read more

Structure–Function of MamC Loop and Its Effect on the *in Vitro* Precipitation of Biomimetic Magnetite Nanoparticles

01-09-2019

MamC, an integral protein of the magnetosome membrane, has recently been proposed as a strong candidate to produce biomimetic (magnetosome-like) magnetite nanoparticles that could be used as an alternative to...

Read more

Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a Tripartite Interaction

01-08-2019

Actinoporins are a group of soluble toxic proteins that bind to membranes containing sphingomyelin (SM) and oli- gomerize to form pores. Sticholysin II (StnII) is a member of the actinoporin...

Read more

Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour

01-07-2019

To satisfy its high energetic demand, the brain depends on the metabolic cooperation of various cell types. For example, astrocytic-derived lactate sustains memory consolidation by serving both as an oxidizable...

Read more

Glucose restriction promotes osteocyte specification by activating a PGC-1α-dependent transcriptional program

03-06-2019

Osteocytes, the most abundant of bone cells, differentiate while they remain buried within the bone matrix. This encasement limits their access to nutrients and likely affects their differentiation, a process...

Read more

ParB dynamics and the critical role of the CTD in DNA condensation unveiled by combined force-fluorescence measurements

01-05-2019

/Bacillus subtilis/ ParB forms multimeric networks involving non-specific DNA binding leading to DNA condensation. Previously, we found that an excess of the free C-terminal domain (CTD) of ParB impeded DNA...

Read more

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer

01-04-2019

Although human epidermal growth factor receptor 2 (HER2)-targeted therapies have dramatically improved the clinical outcome of HER2-positive breast cancer patients, innate and acquired resistance remains an important clinical challenge. New...

Read more

p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton

01-03-2019

Planar cell polarity (PCP) and intercellular junctional complexes establish tissue structure and coordinated behaviors across epithelial sheets. In multiciliated ependymal cells, rotational and translational PCP coordinate cilia beating and direct...

Read more

β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9R239X mice

01-02-2019

Coenzyme Q (CoQ) deficiency has been associated with primary defects in the CoQ biosynthetic pathway or to secondary events. In some cases, the exogenous CoQ supplementation has limited efficacy. In...

Read more

Protector Members